Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation


Onat A., Can G., Hergenc G., Yazici M., Karabulut A. , Albayrak S.

INTERNATIONAL JOURNAL OF OBESITY, vol.31, no.7, pp.1119-1125, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 7
  • Publication Date: 2007
  • Doi Number: 10.1038/sj.ijo.0803552
  • Title of Journal : INTERNATIONAL JOURNAL OF OBESITY
  • Page Numbers: pp.1119-1125

Abstract

Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.